Thursday, August 16, 2018
Research delivers insight into the Insomnia Treatment Drugs Market worth US$ 4,332.4 MN USD by 2026
Do you like this story?
The latest market report published by Credence
Research, Inc. “Global Insomnia
Treatment Drugs Market - Growth, Future Prospects, Competitive
Analysis, 2018 - 2026,” the global insomnia treatment drugs market
was valued at US$ 2,689.6 Mn in 2017, and is expected to reach US$ 4,332.4 Mn
by 2026, expanding at a CAGR of 5.5% from 2018 to 2026.
Browse the full report Insomnia
Treatment Drugs Market - Growth, Future Prospects, Competitive
Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/insomnia-treatment-drugs-market
Market Insights
As per the scientific evidences reported by
American Psychiatric Association (APA) approximately one third of the adults
suffer with insomnia during their lifetime. It is manifested by incessant
problems in falling and staying asleep. Patients suffering with insomnia
experience symptoms such as fatigue, mood disturbances, lack of concentration,
low productivity, loss of appetite etc. Pharmaceutical companies are
relentlessly working to provide effective medication with least side effects.
Orexin antagonist (Belsomra) are being prescribed by physicians throughout the
globe owing to its ability to improve sleep with high degree of tolerability
and limited adverse effects profile. The insomnia treatment drugs market pose
severe threat from alternative treatment such as cognitive behavioral therapy
for insomnia (CBTI) and recent FDA approval of devices such as Fisher Wallace
Stimulator and EBB Insomnia Therapy.
Prescription sleep aids dominate the treatment
type segment on account of key factors such as rising prevalence of insomnia,
increasing stress, addiction etc., which if untreated will eventually result in
chronic illness. Demanding lifestyle and poor sleeping habits result in
secondary insomnia which requires benzodiazepines in combination with zolpidem
for its treatment. Antidepressants are prescribed for patients suffering with
neuropsychiatric ailment. Over the counter sleep aids comprises of
antihistamines, melatonin and dietary supplement. Antihistamine and melatonin
are utilized to produce sedative effect in patients suffering with altered
circadian rhythm and jet lag. Dietary supplements are usually taken by patients
to stimulate the production of melatonin by pineal gland.
Currently North America is leading the
regional segment for insomnia treatment drugs market. Increasing number of
geriatric population suffering with sleep disorders and rising prevalence of
addiction and stress in the youth drive the insomnia treatment drugs market in
North America. Asia Pacific is anticipated to exhibit steady growth during the
forecast period owing to the rising prevalence of insomnia in patients
suffering with chronic pain, hypertension, anxiety etc. Accurate diagnosis of
insomnia has spurred the pharmaceutical companies to manufacture generic drugs
in abundant quantity to cater the medicinal requirements of the huge patient
base in the Asia Pacific region.
The key players actively engaged in the
insomnia treatment drugs market are Merck & Co. Inc., F.Hoffman La-Roche
AG, Mylan N.V., Pernix Therapeutics, Pfizer, Inc., Sanofi S.A., Takeda
Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co. Ltd., Teva
Phamaceutical Industries Ltd, and Vanda Pharmaceuticals, Inc.
Key Market Movements:
- Increasing number of geriatric
population suffering with sleep disorders in the developed nations
- Affordable reimbursement scenario
for drugs prescribed in insomnia treatment
- Growing health awareness leading
to effective insomnia treatment, and developing healthcare infrastructure
drive the market growth in developing nations
Browse the full report Insomnia
Treatment Drugs Market - Growth, Future Prospects, Competitive
Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/insomnia-treatment-drugs-market
Related Reports:
About Us
Credence Research is a worldwide market research and
counseling firm that serves driving organizations, governments, non-legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we've manufactured a firm
extraordinarily prepared to this task.
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Web: https://www.credenceresearch.com
Subscribe to:
Post Comments (Atom)
0 Responses to “Research delivers insight into the Insomnia Treatment Drugs Market worth US$ 4,332.4 MN USD by 2026”
Post a Comment